Current Topics in Medicinal Chemistry


Jia Zhou
Chemical Biology Program
Department of Pharmacology and Toxicology
University of Texas Medical Branch
Galveston, TX

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 17 Issue: 8, March 2017

EDITORIAL (Thematic Issue : Hybrid Compounds as Multitarget Agents in Medicinal Chemistry – Part I) free to download

Volume:17   Issue: 8
Pp: 843-844
Luciana Scotti, Francisco J.B. Mendonca-Junior and Marcus T. Scotti
DOI: 10.2174/156802661708170126200430
Published on: 26 January, 2017

Multi-targeting Andrographolide and its Natural Analogs as Potential Therapeutic Agents

Volume:17   Issue: 8
Pp: 845-857
V. Kishore, Nagendra Sastry Yarla, Anupam Bishayee, Swathi Putta, Ramarao Malla, Nageswara Rao Reddy Neelapu, Surekha Challa, Subhasish Das, Yallappa Shiralgi, Gurumurthy Hegde and Bhadrapura Lakkappa Dhananjaya
DOI: 10.2174/1568026616666160927150452
Published on: 27 September, 2016

The Discovery and Development of Drug Combinations for the Treatment of Various Diseases from Patent Literature (1980-Present)

Volume:17   Issue: 8
Pp: 875-894
Patrycja Kleczkowska, Agnieszka Kowalczyk, Anna Lesniak and Magdalena Bujalska-Zadrozny
DOI: 10.2174/1568026616666160818152257
Published on: 18 August, 2016

Hybrid Drugs as Potential Combatants Against Drug-Resistant Microbes: A Review

Volume:17   Issue: 8
Pp: 895-906
Haythem A. Saadeh and Mohammad S. Mubarak
DOI: 10.2174/1568026616666160927155251
Published on: 27 September, 2016

Hybrid Compounds as Multitarget Directed Anticancer Agents

Volume:17   Issue: 8
Pp: 907-918
Ertan Kucuksayan and Tomris Ozben
DOI: 10.2174/1568026616666160927155515
Published on: 27 September, 2016

Macrolide Hybrid Compounds: Drug Discovery Opportunities in Anti- Infective and Anti-inflammatory Area

Volume:17   Issue: 8
Pp: 919-940
Hana Cipcic Paljetak, Linda Tomaskovic, Mario Matijasic, Mirjana Bukvic, Andrea Fajdetic, Donatella Verbanac and Mihaela Peric
DOI: 10.2174/1568026616666160927160036
Published on: 27 September, 2016

Nitric Oxide-NASIDS Donor Prodrugs as Hybrid Safe Anti-inflammatory Agents

Volume:17   Issue: 8
Pp: 941-955
Khaled R.A. Abdellatif, Eman K.A. Abdelall and Rania B. Bakr
DOI: 10.2174/1568026616666160927153435
Published on: 27 September, 2016